Welcome : Guest

Advaxis, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Advaxis, Inc., which is principally a Clinical Stage Biotechnology Company. Illustrated with 40 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-16096
Price: $2000
Company Type: Public
Pages: 43
Date: November 2015
Market Data Tables: 40

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Immunoglobulin Drugs......3
Table 1: Immunoglobulin Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flebogamma, Gammagard Liquid, Gamunex, Octagam, Privigen and Others......3
Table 2: Intravenous and Subcutaneous Immunoglobulin (IVIG & SCIG) Market by Indication in the US (2014) - Percentage Share Breakdown by Volume for CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), CLL (Chronic Lymphocytic leukaemia), ITP (Idiopathic Thrombocytopenic Purpura), MMN (Multifocal Motor Neuropathy), PID (Primary Immune Deficiency) and Others......4
Table 3: Intravenous Immunoglobulin (IVIG) Market by Region Worldwide (2014) - Percentage Market Share Breakdown by Volume Sales for Australia, Canada, Europe (East & West) and New Zealand, US, Others (Excluding US (Including Japan))......5
Table 4: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2014) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......6
Table 5: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales, for Europe, US, and Others......7
Table 6: Intravenous Immunoglobulin (IVIG) Therapy Market by Region Worldwide (2014) - Percentage Share Breakdown by Volume Sales, for Europe, US, and Others......8
Table 7: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......9
Cancer Drugs......10
Table 8: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......10
Table 9: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......11
Table 10: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......12
Table 11: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......13
Table 12: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......14
Table 13: Cancer-Associated Mucositis Market by Activity Worldwide (2015) – Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......15
Table 14: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......16
Table 15: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......17
Table 16: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......18
Table 17: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......19
Table 18: Standard Injectibles Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Infectives, Blood, Oncology and Others......20
Table 19: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......21
Table 20: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......22
Table 21: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......23
Table 22: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......24
Table 23: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......25
Table 24: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......26
Table 25: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Us, and Others......27
Table 26: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......28
Table 27: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......29
Immunoglobulin Drugs......30
Table 28: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......30
Table 29: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......31
Table 30: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......32
Table 31: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......33
Table 32: Market Shares of Leading Intravenous Immunoglobulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shanghai RAAS Blood Products Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......34
Table 33: Market Shares of Leading Rabies Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......35
Table 34: Market Shares of Leading Tetanus Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Shuyang Group, and Tonrol Biopharm Co, Ltd.......36
Table 35: Market Shares of Leading Immunoglobulin Providing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc. (Gammagard Liquid and S/D), CSL Limited (Privigen, Carimune and Hizentra), Grifiols, S.A. (Flebogamma and Gamunex) and Others......37
Table 36: Market Shares of Leading Immunology/ Immunoglobulin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Others......38
Table 37: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......39
Cancer Drugs......40
Table 38: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......40
Table 39: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......41
Table 40: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......42